Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids

INTRODUCTION: OnabotulinumtoxinA (ONA; Botox, Allergan, Irvine, CA) was discovered for cosmetic use in the mid-1980s for which it was FDA approved in April 2002. AbobotulinumtoxinA (ABO; Dysport, Valeant Pharmaceuticals International, Inc, Montreal, Quebec) was FDA approved in April 2009 for therape...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassir, Ramtin, Kolluru, Aparanjita, Kassir, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889301/
https://www.ncbi.nlm.nih.gov/pubmed/24318416
http://dx.doi.org/10.1007/s13555-013-0033-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889301/
https://www.ncbi.nlm.nih.gov/pubmed/24318416
http://dx.doi.org/10.1007/s13555-013-0033-y

Ejemplares similares